Hidden threat from COVID-19 is long-term mental health issues

Health Industry Hub | May 4, 2020 |
[Total: 1    Average: 4/5]

Medical News: Australia’s mental health system will need to be prepared to deal with long-term mental health issues resulting from the COVID-19 pandemic.

This was the message from Professor Richard Bryant AC, UNSW Sydney Scientia Professor, delivered when he launched this year’s Australian Mental Health Prize via an online forum.

The prize, now in its fifth year, recognises Australians who have made outstanding contributions to the promotion of mental health or the prevention and treatment of mental illness.

“The COVID-19 pandemic is causing unprecedented pressures on people around the world. Apart from the anxieties of infection, people are experiencing considerable stress arising from changes to work structure, unemployment, financial pressures, schooling, concern for family and the elderly, and social isolation,” Professor Bryant said.

Register FREE and join 22,000+ industry professionals receiving the latest industry news and engaging content from Health Industry Hub, the ONLY one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals.

“Prior pandemics such as SARS have shown that mental health issues spike during the outbreak, and more worryingly, can lead to longer-term problems well beyond the pandemic itself,” Professor Bryant explained.

“We need to remember that the hidden threat from COVID-19 is the long-term mental health effects resulting from economic downturns, with many people losing jobs, reduced income, and suffering poor financial security.

“These pandemics also highlight there are some groups who are especially vulnerable to mental health problems during and after a pandemic, including health workers, those in quarantine, and those infected.”

Professor Bryant said that many strategies can be employed to manage mental health in the context of COVID-19.

You may also like PRIME Awards 2020 call for entries – the only awards program dedicated to recognising excellence within Australian healthcare communications, is now open for entries.

“It is important to note that many of the stress reactions many of us experience during the pandemic are not necessarily a mental disorder but rather reflect understandable stress reactions to a severe situation. In this sense, many of the strategies that can be used at this time are those used to help people cope with ongoing stressors rather than mental disorders.”

Professor Bryant pointed out that the spike in mental health issues arising from the COVID-19 crisis will also require new strategies and treatment formats. 

“Health systems are being developed and implemented around the world to try to provide mental health services to hugely increased numbers of people. These services need to adopt innovative treatment formats to accommodate social distancing, potentially large numbers of people requiring help, and targeting people who traditionally do not seek mental health assistance.”

Scientia Professor Henry Brodaty from UNSW Medicine agrees with Professor Bryant’s comments and believes it is more important than ever to publicly acknowledge and address the unprecedented levels of mental health issues that will arise from the COVID-19 crisis.

“The mental health sector will need to adapt to the changing environment we are all currently living through. It is imperative that we acknowledge and celebrate the dedication and work of the mental health sector in assisting Australians through these difficult times,” Professor Brodaty said.

“Mental illness is something that affects our whole community, and the Australian Mental Health Prize is a valuable way to highlight progress being made in this space.”

Professor Brodaty said it was important for those working in the mental health sector to recognise the progress our colleagues are making in research and improving patient outcomes.

Chair of the Australian Mental Health Prize Advisory Group, Ita Buttrose, said the prize is helping to improve mental health care in Australia and ensures mental health stays top of mind for Australians. 

“I have no doubt that the Australian mental health system will rise to the challenge and support Australians through the COVID-19 crisis,” Ms Buttrose said.

“I look forward to discovering who the winner of this year’s prize is and learning more about some of the world-class work being done in the field of mental health.”

UNSW Medicine places high importance on mental health research and works with many other mental health institutions and individuals in this area.

“We must recognise and acknowledge those individuals who are making headway in the area of mental health,” concluded Professor Bryant.

“We encourage clinicians, health professionals, community groups and individuals to nominate people whom they feel are making a real difference in the area of mental health research, advocacy or service delivery for the 2020 Australian Mental Health Prize.”

How To Nominate

To enter, nominees must provide a CV and 200 words outlining the work being undertaken and how it is making an impact. Nomination forms can be obtained from:

Entries close on 30 August 2020.

About the author

About the author

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam luctus finibus scelerisque. Nunc bibendum ipsum sed augue fringilla fringilla. Nullam at consectetur leo. Praesent viverra rutrum porta. Quisque vitae mi vel purus vulputate tincidunt. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Suspendisse et mi quis nisi rhoncus feugiat at ac tellus. Sed aliquam sodales nulla ac auctor. Sed pretium lobortis purus accumsan ullamcorper. Phasellus sodales vel odio in lobortis. Duis maximus sagittis bibendum. Interdum et malesuada fames ac ante ipsum primis in faucibus. Nunc dictum tincidunt ipsum in vestibulum. Donec ut sem consectetur, aliquam quam vitae, pharetra orci. Nam egestas non velit eu rhoncus. Duis congue neque non lacus tincidunt porta. Vestibulum ultricies pulvinar sem, molestie congue dui aliquet non.
  • Ut imperdiet leo id lorem fermentum consectetur.
  • Ut vitae orci et dui varius tincidunt.
  • Ut id magna non libero vestibulum pharetra ac faucibus nulla.
Aliquam erat volutpat. Vestibulum vitae varius diam. Nulla eget congue ante. Nunc ullamcorper sagittis augue vel dictum. Mauris finibus nibh ut pulvinar auctor. Vestibulum ut faucibus nisi. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Quisque porta tortor ac justo malesuada elementum. Nulla tellus ante, cursus nec ex sit amet, suscipit bibendum arcu. Duis posuere orci dui, et mollis enim dictum at. Sed ullamcorper, sapien ut vulputate viverra, sem purus porttitor tellus, nec mattis mauris ligula sed risus. Nulla sagittis id ipsum eu mattis. Link to full profile

Leadership & Management

Leadership Management Qualities - COVID-19 wiping out hard-won gains by women in STEM

COVID-19 wiping out hard-won gains by women in STEM

Health Industry Hub | June 1, 2020 |

Hard-won gains for women’s advancement in the science, technology, engineering and maths (STEM) workforce are now at risk of a […]


News & Trends - Medical Technology

MedTech News - New agreement to end public hospitals' “harvesting” of privately insured patients

New agreement to end public hospital “harvesting” of privately insured patients

Health Industry Hub | June 1, 2020 |

MedTech News: The new National Health Reform Agreement has the potential to end the practice of public hospitals “harvesting” privately […]


News & Trends - Pharmaceuticals

Pharma News - GSK's targeted therapy for asthma gains PBS listing for self-administration delivery

GSK’s targeted therapy for asthma gains PBS listing for self-administration delivery

Health Industry Hub | June 1, 2020 |

Pharma News: From 1 June 2020, GSK Australia’s new pre-filled pen (autoinjector) for the self-administration of its targeted therapy for […]


News & Trends - Pharmaceuticals

Pharma News - Major changes to opioid PBS listings effective 1 June

Major changes to opioid PBS listings effective 1 June

Health Industry Hub | June 1, 2020 |

Commencing 1 June 2020, the Pharmaceutical Benefits Scheme (PBS) listings for opioid medicines will change including Tramal (tramadol) and Panadeine […]